Ashley Johnson, PA
Physician Assistant · Lincoln, NENPI 1790267227
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,144 of the $7,227 with a category attached, or 85.0%. 32 manufacturers reported payments, led by Sanofi at 31.6% of the total. Among physician assistant clinicians in NE with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 271 payments — averaging $26.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi$2K
- AstraZeneca$1K
- Blueprint Medicines Corporation$791
- Aimmune Therapeutics, Inc.$375
- Amgen$298
- GSK$245
- plus $2K from 26 others
What the payments were for
- Consulting fees$90%
- Speaking & faculty fees$97513%
- Food & beverage$6,14485%
- Education$991%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi | 102 | $2,281 |
| AstraZeneca | 44 | $1,475 |
| Blueprint Medicines Corporation | 4 | $791 |
| Aimmune Therapeutics, Inc. | 3 | $375 |
| Amgen(2 entities) | 16 | $298 |
| GSK | 16 | $245 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $202 |
| Regeneron Healthcare Solutions, Inc. | 5 | $171 |
| Pfizer | 6 | $170 |
| CSL Behring | 7 | $156 |
| Novartis | 7 | $123 |
| Mentor Worldwide LLC | 3 | $112 |
| AbbVie | 6 | $95 |
| Octapharma USA, Inc. | 3 | $92 |
| Optinose US, Inc. | 4 | $83 |
| Kaleo, Inc. | 5 | $73 |
| Grifols USA, LLC | 3 | $60 |
| Genentech USA, Inc. | 4 | $54 |
| Pharming Healthcare, Inc. | 4 | $51 |
| Genentech, Inc. | 1 | $49 |
| Sanofi-aventis U.S. LLC | 2 | $36 |
| Hospira, Inc. | 2 | $34 |
| Alk-abello, Inc | 2 | $30 |
| Biocryst US Sales Co., LLC | 2 | $28 |
| Boehringer Ingelheim | 2 | $27 |
| Incyte Corporation | 1 | $24 |
| Corium, LLC | 1 | $20 |
| Abiomed | 1 | $19 |
| Lilly USA, LLC | 1 | $16 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| Mylan Specialty L.p. | 1 | $15 |
| ADMA Biomanufacturing LLC | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,227 in reported general payments places this provider in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 31 | $156,666 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 86 | $59,295 |
| XolairOmalizumab | 16 | $38,358 |
| Breo ElliptaFluticasone/Vilanterol | 54 | $25,455 |
| Arnuity ElliptaFluticasone Furoate | 45 | $9,515 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 51 | $8,300 |
| Advair HfaFluticasone Propion/Salmeterol | 17 | $7,227 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 14 | $6,472 |
| SymbicortBudesonide/Formoterol Fumarate | 17 | $4,339 |
| Fluticasone Propionate | 130 | $2,452 |
| Azelastine Hcl | 50 | $1,801 |
| Montelukast Sodium | 169 | $1,479 |
| Ipratropium Bromide | 24 | $1,388 |
| Olopatadine Hcl | 11 | $676 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 21 | $424 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| GSKTrelegy Ellipta, Breo Ellipta, Arnuity Ellipta, Anoro Ellipta | $245 | $100,737199 claims |
| Genentech, Inc.Xolair | $49 | $38,35816 claims |
| AstraZenecaSymbicort | $1,475 | $4,33917 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,127 physician assistant providers in Nebraska.
Other physician assistant in Lincoln
- Courtney MaresLincoln$13K
- Jacklynn KmentLincoln$10K
- Bethany LambertLincoln$9K
- Kelsey WerginLincoln$8K
- Makayla DoolittleLincoln$7K
- Christina MeyerLincoln$7K
- Shaun RingLincoln$7K
- Katelyn EspinozaLincoln$7K
- Bailee CookLincoln$6K
- Angela MoserLincoln$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.